Results 61 to 70 of about 868 (155)

Multiple liver-directed therapy including theraspheres for recurrent metastatic jejeunal carcinoid tumor [PDF]

Endocrine Abstracts, 2016
Emadi Budoor Al, Mohammed Ahmed, Hamad Alsuhaibani, Tarek Amin, Hindi Hindi Al, Mahmoud Tuli   +5 more
openaire   +1 more source

Clinical and dosimetric considerations for yttrium-90 glass microspheres radioembolization of intrahepatic cholangiocarcinoma, metastatic colorectal carcinoma, and metastatic neuroendocrine carcinoma: recommendations from an international multidisciplinary working group

Purpose: The TheraSphere Global Steering Committee reconvened to review clinical data and address knowledge gaps related to treatment and dosimetry in non-HCC indications using Yttrium-90 (90Y) glass microspheres. Methods: A PubMed search was performed.
Herman, Joseph M., Salem, Riad, Lam, Marnix, Chiesa, Carlo, Sze, Daniel Y., Sze, Daniel, Herman, Joseph M, Padia, Siddharth A, Kim, Edward, Padia, Siddharth A., Fowers, Kirk, Sze, Daniel Y, Kappadath, S. Cheenu, Sangro, Bruno, Kappadath, S Cheenu, Leung, Thomas, Garin, Etienne, Haste, Paul, Toskich, Beau   +18 more
core   +2 more sources

A Pilot Study of Pembrolizumab in Combination With Y90 Radioembolization in Subjects With Poor Prognosis Hepatocellular Carcinoma [PDF]

BACKGROUND: Combination checkpoint inhibition therapy with yttrium-90 (Y90) radioembolization represents an emerging area of interest in the treatment of advanced hepatocellular carcinoma (HCC).
Yu, Shawn, Yu, Menggang, Sanoff, Hanna K, Helft, Paul R, McRee, Autumn Jackson, Harris, William P, Somasundaram, Ashwin, Johnson, Matthew S, Keane, Barry, Mauro, David M, O’Neil, Bert   +10 more
core   +1 more source

Transarterial Radioembolization: Overview of Radioembolic Devices. [PDF]

Semin Intervent Radiol, 2023
Serhal M, Gordon AC, Brown DB, Toskich BB, Lewandowski RJ.   +4 more
europepmc   +1 more source

Microsphères d'yttrium-90 dans le traitement des tumeurs hépatiques

, 2013
La radioembolisation est une nouvelle modalité thérapeutique qui consiste en l'injection intra-artérielle hépatique de microsphères d'Yttrium 90. Ces microsphères, commercialisées sous le nom de SIR-Sphères® ou de TheraSphere® sont des dispositifs ...
HARTMANN, Daniel, AZIBI, Isma
core  

Digital twins for optimising intra-arterial therapy in liver cancer

International audienceSelective internal radiation therapy (SIRT) has emerged as an effective and safe treatment for patients with unresectable and chemorefractory hepatocellular carcinoma (HCC).
Saint-Jalmes, Hervé, Rolland, Yan, Cutrì, Elena, Petit, Antoine, Eliat, Pierre-Antoine, de Gaetano, Francesco, Rochette, Michel, Bézy-Wendling, Johanne   +7 more
core   +1 more source

Effect of predicted lung mass versus fixed mass regimes on lung dose in SIRT (90 Y)

This work sought to investigate the impact of fixed lung mass regime versus individualized measures on the lung absorbed dose in90Y therapy. 14 patients were injected with 3-5 mCi99mTc-MAA pursued by whole-body scans with 15% photo-peak window width at ...
DEMİR, MUSTAFA, Abuqbeitah, Mohammad
core   +1 more source

Iatrogenic portobiliary fistula treated with covered stent following percutaneous transhepatic biliary drainage. [PDF]

Radiol Case Rep
Scott E, Forsberg C, Lancaster W, Hannegan C, Leo M, Green C, Gayed A.   +6 more
europepmc   +1 more source

Radioembolization Practice in North America Versus Europe: Results from a Global Survey. [PDF]

Curr Oncol
Keane G, Lam MGEH, Braat AJAT, Bruijnen RCG, Kaufmann N, de Jong HWAM, Salem R, Smits MLJ.   +7 more
europepmc   +1 more source

Tumor absorbed dose and outcomes after Y-90 glass radioembolization for colorectal liver metastases: does dose escalation improve survival in real-world practice? [PDF]

Eur J Nucl Med Mol Imaging
Topcuoglu OM, Uzunoglu B, Orhan T, Yucel IN, Gormez A, Toklu T, Selcuk NA.   +6 more
europepmc   +1 more source